Ligand validation:6WND

GOL: GLYCEROL

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6WND_GOL_B_502	62%	41%	0.138	0.93	1.01	1.29	-	-	2	0	100%	1
6WND_GOL_C_504	48%	53%	0.136	0.878	0.9	0.91	-	-	0	0	100%	1
6WND_GOL_C_502	41%	47%	0.207	0.922	0.98	1.07	1	1	0	0	100%	1
6WND_GOL_B_507	37%	48%	0.183	0.881	0.8	1.18	-	1	1	0	100%	1
6WND_GOL_A_502	35%	55%	0.238	0.929	0.6	1.11	-	-	1	0	100%	1
6WND_GOL_C_507	34%	50%	0.19	0.872	1.05	0.88	1	-	2	0	100%	1
6WND_GOL_A_505	33%	53%	0.158	0.837	0.89	0.92	-	-	0	0	100%	1
6WND_GOL_B_503	22%	45%	0.193	0.808	0.9	1.23	-	1	0	0	100%	1
6WND_GOL_A_504	19%	54%	0.266	0.864	0.81	0.98	-	-	0	0	100%	1
6WND_GOL_C_508	18%	50%	0.26	0.844	1.03	0.89	-	-	0	0	100%	1
6WND_GOL_B_506	16%	51%	0.24	0.806	0.94	0.94	-	-	1	0	100%	1
6WND_GOL_A_503	13%	46%	0.279	0.816	1.25	0.86	-	-	2	0	100%	1
6WND_GOL_C_509	8%	52%	0.26	0.737	0.82	1.03	-	-	1	0	100%	1
6WND_GOL_C_503	8%	51%	0.373	0.851	0.86	1.04	-	-	0	0	100%	1
7SZF_GOL_B_504	82%	51%	0.088	0.943	0.84	1.06	-	-	0	0	100%	1
7SZE_GOL_B_503	65%	44%	0.131	0.934	0.99	1.18	-	1	0	0	100%	1
6WNC_GOL_A_502	27%	86%	0.172	0.819	0.08	0.63	-	-	1	0	100%	1
7SZG_GOL_C_503	17%	95%	0.188	0.763	0.08	0.32	-	-	1	0	100%	1
2NT0_GOL_D_506	100%	73%	0.016	0.997	0.3	0.72	-	-	0	0	100%	1
2YOQ_GOL_A_1196	100%	35%	0.024	0.996	0.38	2.12	-	2	0	0	100%	1
3V5K_GOL_D_276	100%	96%	0.022	0.995	0.21	0.17	-	-	0	0	100%	1
4KFD_GOL_D_806	100%	57%	0.024	0.995	0.41	1.21	-	-	0	0	100%	1
4KFE_GOL_E_803	100%	63%	0.024	0.995	0.31	1.07	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.